About
Capsulomics develops liquid biopsy tests for cancer detection and monitoring by analyzing cell-free DNA methylation patterns to stratify patient risk of disease progression.
Explore Capsulomics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.